Business Description
BioNeutra Global Corp
NAICS : 311230
SIC : 1051
ISIN : CA09073L1067
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | -0.39 | |||||
Debt-to-Equity | -1.23 | |||||
Debt-to-EBITDA | -21.71 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.47 | |||||
Beneish M-Score | -3.53 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.1 | |||||
3-Year EBITDA Growth Rate | 37 | |||||
3-Year EPS without NRI Growth Rate | 13 | |||||
3-Year FCF Growth Rate | -21.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.99 | |||||
9-Day RSI | 37.68 | |||||
14-Day RSI | 44.3 | |||||
6-1 Month Momentum % | 366.67 | |||||
12-1 Month Momentum % | 833.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.47 | |||||
Quick Ratio | 0.25 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 232.69 | |||||
Days Sales Outstanding | 34.57 | |||||
Days Payable | 720.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -6.56 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.4 | |||||
Operating Margin % | -12.64 | |||||
Net Margin % | -18.52 | |||||
FCF Margin % | 5.83 | |||||
ROA % | -12.45 | |||||
ROIC % | -13.73 | |||||
ROC (Joel Greenblatt) % | -15.52 | |||||
ROCE % | -145.77 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 7.69 | |||||
PS Ratio | 0.38 | |||||
Price-to-Free-Cash-Flow | 6.25 | |||||
Price-to-Operating-Cash-Flow | 5.88 | |||||
EV-to-EBIT | -7.4 | |||||
EV-to-EBITDA | -29.6 | |||||
EV-to-Revenue | 0.92 | |||||
EV-to-FCF | 15.69 | |||||
Earnings Yield (Greenblatt) % | -13.51 | |||||
FCF Yield % | 14.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BioNeutra Global Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 11.383 | ||
EPS (TTM) (C$) | -0.06 | ||
Beta | 2.87 | ||
Volatility % | 516.88 | ||
14-Day RSI | 44.3 | ||
14-Day ATR (C$) | 0.003716 | ||
20-Day SMA (C$) | 0.10275 | ||
12-1 Month Momentum % | 833.33 | ||
52-Week Range (C$) | 0.005 - 0.16 | ||
Shares Outstanding (Mil) | 46.7 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BioNeutra Global Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BioNeutra Global Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
BioNeutra Global Corp Frequently Asked Questions
What is BioNeutra Global Corp(TSXV:BGA)'s stock price today?
When is next earnings date of BioNeutra Global Corp(TSXV:BGA)?
Does BioNeutra Global Corp(TSXV:BGA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |